What's new. News and updates from Ali Ramezani
Recent publications, conference talks, patent filings, funding, awards, and milestones from the lab and the Nephrova and Medistant programs.
Travel support award for the Rocky Mountain Workshop on Trustworthy & Responsible AI
Selected as a participant, with travel support, for the workshop at the University of Colorado Boulder on November 4–5, 2026.
Presented bladder PuO₂ research at ANESTHESIOLOGY 2026
Presented “Physics-Based Estimation of Bladder PuO₂ Improves AKI Discrimination After Cardiac Surgery” at the ANESTHESIOLOGY® 2026 Annual Meeting in San Diego, supported by a University of Utah Graduate School Professional Development Supplement.
Three new patent filings: two U.S. provisionals and a PCT application
Filed U.S. provisional applications on estimating local analyte parameters using flow-perturbation intervals (September 17) and a Just-in-Time Smart Cart (October 16), plus an international PCT application for the Diffusion Adjusted Sensor System (October 19).
Abstract accepted at the SCCM 2027 Critical Care Congress
“Peripheral NIRS Tracks Within-Animal MAP Changes in Porcine Hemorrhage and Resuscitation” will be presented in San Diego in March 2027 and published in the March 2027 supplement of Critical Care Medicine.
Rode 100 miles for childhood cancer research
Completed the Great Cycle Challenge USA, cycling 100 miles and raising $429 for the Children’s Cancer Research Fund.
Investigator and Lead Engineer on an NIH SBIR award
Leading engineering for a National Institutes of Health Small Business Innovation Research award on urinary oxygen monitoring for early detection of acute kidney injury (KSCUBE; University of Utah subaward of $315,335).
Passed the Ph.D. proposal defense
Successfully defended the doctoral research proposal at the University of Utah, advancing to Ph.D. candidacy in Biomedical Engineering.
U.S. provisional patent filed for hybrid optical-electrical connectors
“Hybrid Optical-Electrical Connectors with an Optical Coupling Medium” (Application 64/130,380) covers connector technology for biomedical sensing applications.
Diffusion-correction paper published in Scientific Reports
“Correcting Diffusion Artifacts in Urinary Oxygen Tension Monitoring” restores the diagnostic value of bedside urinary PO₂ by removing oxygen-diffusion artifacts.
Named an MIT Catalyst Fellow
Selected for MIT’s translational research program advancing high-impact healthcare technologies from concept toward clinical and commercial viability.
International PCT application published for fluid transit-time tracking
“System and Method for Tracking Fluid Transit Time in a Conduit” (WO2026060269A1) extends the urinary-oxygen monitoring program toward commercial translation.
U.S. provisional patent filed: “Diffusion Adjusted Sensor System and Method”
Protecting the diffusion-correction method behind more trustworthy bedside urinary-oxygen monitoring.
Transit-time algorithm paper published in the Journal of Clinical Monitoring and Computing
An algorithm establishing sample validity so a bedside oxygen reading reflects the kidney rather than the tubing.